Table 1.
Patient characteristics
| Case | Age & sex | Background | Type | CRP/WBC | ICU | Sputum culture | Blood culture | Bacterial infection | Chest CT pattern | Therapy | Prognosis |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 70 M | Steroid | A | ND | – | ND | ND | – | Interstitial pneumonia | Oseltamivir | Alive |
| 2 | 86 M | Diabetes | A | 11·7/11 900 | – | ND | ND | – | Interstitial pneumonia | Amantadine | Died* |
| 3 | 68 M | Parkinson | A | 21/4100 | + | Pseudomonas aeruginosa, MRSA | ND | + | Interstitial pneumonia | Amantadine | Alive |
| 4 | 40 F | Asthma | A | 14·7/12 700 | + | ND | – | – | Interstitial pneumonia | Oseltamivir + antibiotics + steroid | Alive |
| 5 | 77 M | CHD | A | 9·5/8200 | + | – | – | – | Interstitial pneumonia + effusion | Oseltamivir + antibiotics | Alive |
| 6 | 79 M | CHD | A | 15·4/6600 | + | – | – | – | Interstitial pneumonia + effusion | Oseltamivir + antibiotics | Died* |
| 7 | 91 F | Diabetes, hypertension | A | 4·5/8900 | – | Streptococcus pneumoniae | – | + | Bronchopneumonia | Oseltamivir + antibiotics | Alive |
| 8 | 41 F | Diabetes | A | 11·8/26 200 | + | MSSA | MSSA | + | Bronchopneumonia | Oseltamivir + antibiotics | Alive |
| 9 | 60 F | Asthma | A | 18·4/16 300 | – | MRSA + MSSA | – | + | Bronchopneumonia | Oseltamivir + antibiotics | Alive |
| 10 | 30 F | – | A | 4·49/5000 | – | Streptococcus pneumoniae | ND | + | Bronchopneumonia | Oseltamivir + antibiotics | Alive |
| 11 | 82 F | Diabetes | A | 2·46/5300 | – | Gram stain (+), not identified | ND | + | Bronchopneumonia | Oseltamivir + antibiotics | Alive |
| 12 | 38 F | – | A | 8·85/14 300 | – | – | ND | – | Cryptogenic organizing pneumonia | Zanamivir | Alive |
CHD, coronary heart disease; ND, not done; MRSA, methicillin‐resistant Staphylococcus aureus; MSSA, methicillin‐sensitive Staphylococcus aureus.
*Died of respiratory failure.